HEADER IMMUNE SYSTEM 12-JUN-23 8JPS TITLE STRUCTURE OF DUFFY ANTIGEN RECEPTOR FOR CHEMOKINES (DARC)/ACKR1 IN TITLE 2 COMPLEX WITH THE CHEMOKINE, CCL7 (COMPOSITE MAP) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ATYPICAL CHEMOKINE RECEPTOR 1; COMPND 3 CHAIN: B, A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: C-C MOTIF CHEMOKINE 7; COMPND 7 CHAIN: D, C; COMPND 8 SYNONYM: MONOCYTE CHEMOATTRACTANT PROTEIN 3,MONOCYTE CHEMOTACTIC COMPND 9 PROTEIN 3,MCP-3,NC28,SMALL-INDUCIBLE CYTOKINE A7; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACKR1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CCL7, MCP3, SCYA6, SCYA7; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS GPCR, SIGNALING PROTEIN, IMMUNE SYSTEM EXPDTA ELECTRON MICROSCOPY AUTHOR R.BANERJEE,B.KHANPPNAVAR,J.MAHARANA,S.SAHA,V.M.KORKHOV,A.K.SHUKLA REVDAT 3 04-SEP-24 8JPS 1 JRNL REVDAT 2 14-AUG-24 8JPS 1 JRNL REVDAT 1 31-JUL-24 8JPS 0 JRNL AUTH S.SAHA,B.KHANPPNAVAR,J.MAHARANA,H.KIM,C.M.C.CARINO,C.DALY, JRNL AUTH 2 S.HOUSTON,S.SHARMA,N.ZAIDI,A.DALAL,S.MISHRA,M.GANGULY, JRNL AUTH 3 D.TIWARI,P.KUMARI,G.D.JHINGAN,P.N.YADAV,B.PLOUFFE,A.INOUE, JRNL AUTH 4 K.Y.CHUNG,R.BANERJEE,V.M.KORKHOV,A.K.SHUKLA JRNL TITL MOLECULAR MECHANISM OF DISTINCT CHEMOKINE ENGAGEMENT AND JRNL TITL 2 FUNCTIONAL DIVERGENCE OF THE HUMAN DUFFY ANTIGEN RECEPTOR. JRNL REF CELL V. 187 4751 2024 JRNL REFN ISSN 1097-4172 JRNL PMID 39089252 JRNL DOI 10.1016/J.CELL.2024.07.005 REMARK 2 REMARK 2 RESOLUTION. 3.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, COOT, PHENIX, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : FLEXIBLE FIT REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.650 REMARK 3 NUMBER OF PARTICLES : 308174 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8JPS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-JUN-23. REMARK 100 THE DEPOSITION ID IS D_1300038545. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : DUFFY ANTIGEN RECEPTOR FOR REMARK 245 CHEMOKINES (DARC)/ACKR1 IN REMARK 245 COMPLEX WITH THE CHEMOKINE, REMARK 245 CCL7; DUFFY ANTIGEN RECEPTOR REMARK 245 FOR CHEMOKINES (DARC)/ACKR1; REMARK 245 CCL7 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5800.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D, A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 230 REMARK 465 LEU B 231 REMARK 465 LYS B 232 REMARK 465 LYS B 233 REMARK 465 ALA B 234 REMARK 465 LEU B 235 REMARK 465 GLY B 236 REMARK 465 MET B 237 REMARK 465 GLY B 238 REMARK 465 PRO B 239 REMARK 465 GLY A 230 REMARK 465 LEU A 231 REMARK 465 LYS A 232 REMARK 465 LYS A 233 REMARK 465 ALA A 234 REMARK 465 LEU A 235 REMARK 465 GLY A 236 REMARK 465 MET A 237 REMARK 465 GLY A 238 REMARK 465 PRO A 239 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU B 67 CG CD1 CD2 REMARK 470 LEU B 71 CG CD1 CD2 REMARK 470 ARG B 156 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 161 CG CD OE1 NE2 REMARK 470 LYS B 269 CG CD CE NZ REMARK 470 ARG D 14 CG CD NE CZ NH1 NH2 REMARK 470 PHE D 15 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASN D 17 CG OD1 ND2 REMARK 470 LYS D 19 CG CD CE NZ REMARK 470 LYS D 22 CG CD CE NZ REMARK 470 ARG D 24 CG CD NE CZ NH1 NH2 REMARK 470 GLU D 26 CG CD OE1 OE2 REMARK 470 ARG D 29 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 30 CG CD NE CZ NH1 NH2 REMARK 470 PHE D 43 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS D 44 CG CD CE NZ REMARK 470 LYS D 46 CG CD CE NZ REMARK 470 LEU D 47 CG CD1 CD2 REMARK 470 ASP D 48 CG OD1 OD2 REMARK 470 GLN D 57 CG CD OE1 NE2 REMARK 470 LYS D 58 CG CD CE NZ REMARK 470 TRP D 59 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP D 59 CZ3 CH2 REMARK 470 GLN D 61 CG CD OE1 NE2 REMARK 470 ASP D 62 CG OD1 OD2 REMARK 470 LYS D 65 CG CD CE NZ REMARK 470 HIS D 66 CG ND1 CD2 CE1 NE2 REMARK 470 LYS D 69 CG CD CE NZ REMARK 470 LEU A 67 CG CD1 CD2 REMARK 470 LEU A 71 CG CD1 CD2 REMARK 470 ARG A 156 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 161 CG CD OE1 NE2 REMARK 470 LEU A 179 CG CD1 CD2 REMARK 470 MET A 243 CG SD CE REMARK 470 LYS A 269 CG CD CE NZ REMARK 470 ARG C 14 CG CD NE CZ NH1 NH2 REMARK 470 PHE C 15 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASN C 17 CG OD1 ND2 REMARK 470 LYS C 19 CG CD CE NZ REMARK 470 ILE C 20 CG1 CG2 CD1 REMARK 470 LYS C 22 CG CD CE NZ REMARK 470 GLN C 23 CG CD OE1 NE2 REMARK 470 ARG C 24 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 26 CG CD OE1 OE2 REMARK 470 ARG C 29 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 30 CG CD NE CZ NH1 NH2 REMARK 470 THR C 32 OG1 CG2 REMARK 470 LYS C 44 CG CD CE NZ REMARK 470 LYS C 46 CG CD CE NZ REMARK 470 ASP C 48 CG OD1 OD2 REMARK 470 GLU C 50 CG CD OE1 OE2 REMARK 470 THR C 56 OG1 CG2 REMARK 470 GLN C 57 CG CD OE1 NE2 REMARK 470 LYS C 58 CG CD CE NZ REMARK 470 TRP C 59 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP C 59 CZ3 CH2 REMARK 470 GLN C 61 CG CD OE1 NE2 REMARK 470 PHE C 63 CG CD1 CD2 CE1 CE2 CZ REMARK 470 MET C 64 CG SD CE REMARK 470 LYS C 65 CG CD CE NZ REMARK 470 HIS C 66 CG ND1 CD2 CE1 NE2 REMARK 470 LYS C 69 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 58 178.01 -59.71 REMARK 500 SER B 60 -8.03 -57.18 REMARK 500 SER B 122 -166.38 -79.97 REMARK 500 PRO D 37 -164.98 -70.97 REMARK 500 ARG D 38 133.19 -35.01 REMARK 500 ASP A 58 176.34 -58.24 REMARK 500 SER A 60 -9.50 -57.54 REMARK 500 PHE A 64 -6.16 -59.93 REMARK 500 SER A 122 -166.01 -79.82 REMARK 500 MET A 243 65.13 63.86 REMARK 500 TRP A 247 3.14 -69.36 REMARK 500 PRO C 37 -162.33 -71.64 REMARK 500 ARG C 38 130.04 -30.04 REMARK 500 LEU C 47 30.73 -93.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-36488 RELATED DB: EMDB REMARK 900 STRUCTURE OF DUFFY ANTIGEN RECEPTOR FOR CHEMOKINES (DARC)/ACKR1 IN REMARK 900 COMPLEX WITH THE CHEMOKINE, CCL7 REMARK 900 RELATED ID: EMD-37212 RELATED DB: EMDB REMARK 900 STRUCTURE OF DUFFY ANTIGEN RECEPTOR FOR CHEMOKINES (DARC)/ACKR1 IN REMARK 900 COMPLEX WITH THE CHEMOKINE, CCL7 (RECEPTOR ORIGINAL MAP) REMARK 900 RELATED ID: EMD-37214 RELATED DB: EMDB REMARK 900 STRUCTURE OF DUFFY ANTIGEN RECEPTOR FOR CHEMOKINES (DARC)/ACKR1 IN REMARK 900 COMPLEX WITH THE CHEMOKINE, CCL7 (LIGAND/CCL7 FOCUSED MAP) DBREF 8JPS B 46 312 UNP Q16570 ACKR1_HUMAN 46 312 DBREF 8JPS D 8 70 UNP P80098 CCL7_HUMAN 31 93 DBREF 8JPS A 46 312 UNP Q16570 ACKR1_HUMAN 46 312 DBREF 8JPS C 8 70 UNP P80098 CCL7_HUMAN 31 93 SEQRES 1 B 267 GLU ALA ALA ALA PRO CYS HIS SER CYS ASN LEU LEU ASP SEQRES 2 B 267 ASP SER ALA LEU PRO PHE PHE ILE LEU THR SER VAL LEU SEQRES 3 B 267 GLY ILE LEU ALA SER SER THR VAL LEU PHE MET LEU PHE SEQRES 4 B 267 ARG PRO LEU PHE ARG TRP GLN LEU CYS PRO GLY TRP PRO SEQRES 5 B 267 VAL LEU ALA GLN LEU ALA VAL GLY SER ALA LEU PHE SER SEQRES 6 B 267 ILE VAL VAL PRO VAL LEU ALA PRO GLY LEU GLY SER THR SEQRES 7 B 267 ARG SER SER ALA LEU CYS SER LEU GLY TYR CYS VAL TRP SEQRES 8 B 267 TYR GLY SER ALA PHE ALA GLN ALA LEU LEU LEU GLY CYS SEQRES 9 B 267 HIS ALA SER LEU GLY HIS ARG LEU GLY ALA GLY GLN VAL SEQRES 10 B 267 PRO GLY LEU THR LEU GLY LEU THR VAL GLY ILE TRP GLY SEQRES 11 B 267 VAL ALA ALA LEU LEU THR LEU PRO VAL THR LEU ALA SER SEQRES 12 B 267 GLY ALA SER GLY GLY LEU CYS THR LEU ILE TYR SER THR SEQRES 13 B 267 GLU LEU LYS ALA LEU GLN ALA THR HIS THR VAL ALA CYS SEQRES 14 B 267 LEU ALA ILE PHE VAL LEU LEU PRO LEU GLY LEU PHE GLY SEQRES 15 B 267 ALA LYS GLY LEU LYS LYS ALA LEU GLY MET GLY PRO GLY SEQRES 16 B 267 PRO TRP MET ASN ILE LEU TRP ALA TRP PHE ILE PHE TRP SEQRES 17 B 267 TRP PRO HIS GLY VAL VAL LEU GLY LEU ASP PHE LEU VAL SEQRES 18 B 267 ARG SER LYS LEU LEU LEU LEU SER THR CYS LEU ALA GLN SEQRES 19 B 267 GLN ALA LEU ASP LEU LEU LEU ASN LEU ALA GLU ALA LEU SEQRES 20 B 267 ALA ILE LEU HIS CYS VAL ALA THR PRO LEU LEU LEU ALA SEQRES 21 B 267 LEU PHE CYS HIS GLN ALA THR SEQRES 1 D 63 SER THR THR CYS CYS TYR ARG PHE ILE ASN LYS LYS ILE SEQRES 2 D 63 PRO LYS GLN ARG LEU GLU SER TYR ARG ARG THR THR SER SEQRES 3 D 63 SER HIS CYS PRO ARG GLU ALA VAL ILE PHE LYS THR LYS SEQRES 4 D 63 LEU ASP LYS GLU ILE CYS ALA ASP PRO THR GLN LYS TRP SEQRES 5 D 63 VAL GLN ASP PHE MET LYS HIS LEU ASP LYS LYS SEQRES 1 A 267 GLU ALA ALA ALA PRO CYS HIS SER CYS ASN LEU LEU ASP SEQRES 2 A 267 ASP SER ALA LEU PRO PHE PHE ILE LEU THR SER VAL LEU SEQRES 3 A 267 GLY ILE LEU ALA SER SER THR VAL LEU PHE MET LEU PHE SEQRES 4 A 267 ARG PRO LEU PHE ARG TRP GLN LEU CYS PRO GLY TRP PRO SEQRES 5 A 267 VAL LEU ALA GLN LEU ALA VAL GLY SER ALA LEU PHE SER SEQRES 6 A 267 ILE VAL VAL PRO VAL LEU ALA PRO GLY LEU GLY SER THR SEQRES 7 A 267 ARG SER SER ALA LEU CYS SER LEU GLY TYR CYS VAL TRP SEQRES 8 A 267 TYR GLY SER ALA PHE ALA GLN ALA LEU LEU LEU GLY CYS SEQRES 9 A 267 HIS ALA SER LEU GLY HIS ARG LEU GLY ALA GLY GLN VAL SEQRES 10 A 267 PRO GLY LEU THR LEU GLY LEU THR VAL GLY ILE TRP GLY SEQRES 11 A 267 VAL ALA ALA LEU LEU THR LEU PRO VAL THR LEU ALA SER SEQRES 12 A 267 GLY ALA SER GLY GLY LEU CYS THR LEU ILE TYR SER THR SEQRES 13 A 267 GLU LEU LYS ALA LEU GLN ALA THR HIS THR VAL ALA CYS SEQRES 14 A 267 LEU ALA ILE PHE VAL LEU LEU PRO LEU GLY LEU PHE GLY SEQRES 15 A 267 ALA LYS GLY LEU LYS LYS ALA LEU GLY MET GLY PRO GLY SEQRES 16 A 267 PRO TRP MET ASN ILE LEU TRP ALA TRP PHE ILE PHE TRP SEQRES 17 A 267 TRP PRO HIS GLY VAL VAL LEU GLY LEU ASP PHE LEU VAL SEQRES 18 A 267 ARG SER LYS LEU LEU LEU LEU SER THR CYS LEU ALA GLN SEQRES 19 A 267 GLN ALA LEU ASP LEU LEU LEU ASN LEU ALA GLU ALA LEU SEQRES 20 A 267 ALA ILE LEU HIS CYS VAL ALA THR PRO LEU LEU LEU ALA SEQRES 21 A 267 LEU PHE CYS HIS GLN ALA THR SEQRES 1 C 63 SER THR THR CYS CYS TYR ARG PHE ILE ASN LYS LYS ILE SEQRES 2 C 63 PRO LYS GLN ARG LEU GLU SER TYR ARG ARG THR THR SER SEQRES 3 C 63 SER HIS CYS PRO ARG GLU ALA VAL ILE PHE LYS THR LYS SEQRES 4 C 63 LEU ASP LYS GLU ILE CYS ALA ASP PRO THR GLN LYS TRP SEQRES 5 C 63 VAL GLN ASP PHE MET LYS HIS LEU ASP LYS LYS HELIX 1 AA1 ASP B 58 ALA B 61 5 4 HELIX 2 AA2 LEU B 62 MET B 82 1 21 HELIX 3 AA3 ARG B 85 ARG B 89 5 5 HELIX 4 AA4 GLY B 95 VAL B 113 1 19 HELIX 5 AA5 PRO B 114 LEU B 116 5 3 HELIX 6 AA6 SER B 125 GLY B 158 1 34 HELIX 7 AA7 VAL B 162 THR B 181 1 20 HELIX 8 AA8 THR B 181 ALA B 187 1 7 HELIX 9 AA9 SER B 200 GLU B 202 5 3 HELIX 10 AB1 LEU B 203 PHE B 226 1 24 HELIX 11 AB2 ASN B 244 LEU B 246 5 3 HELIX 12 AB3 TRP B 247 SER B 268 1 22 HELIX 13 AB4 THR B 275 LEU B 295 1 21 HELIX 14 AB5 LEU B 295 ALA B 311 1 17 HELIX 15 AB6 GLN D 57 LEU D 67 1 11 HELIX 16 AB7 ASP A 58 ALA A 61 5 4 HELIX 17 AB8 LEU A 62 MET A 82 1 21 HELIX 18 AB9 ARG A 85 ARG A 89 5 5 HELIX 19 AC1 GLY A 95 VAL A 113 1 19 HELIX 20 AC2 PRO A 114 ALA A 117 5 4 HELIX 21 AC3 SER A 125 LEU A 153 1 29 HELIX 22 AC4 LEU A 153 GLY A 158 1 6 HELIX 23 AC5 VAL A 162 THR A 181 1 20 HELIX 24 AC6 THR A 181 ALA A 187 1 7 HELIX 25 AC7 LEU A 203 GLY A 227 1 25 HELIX 26 AC8 ASN A 244 PHE A 252 5 9 HELIX 27 AC9 TRP A 253 SER A 268 1 16 HELIX 28 AD1 THR A 275 LEU A 295 1 21 HELIX 29 AD2 LEU A 295 THR A 312 1 18 HELIX 30 AD3 GLN C 57 LEU C 67 1 11 SHEET 1 AA1 2 SER B 188 ALA B 190 0 SHEET 2 AA1 2 CYS B 195 LEU B 197 -1 O THR B 196 N GLY B 189 SHEET 1 AA2 3 LEU D 25 ARG D 29 0 SHEET 2 AA2 3 VAL D 41 THR D 45 -1 O LYS D 44 N GLU D 26 SHEET 3 AA2 3 GLU D 50 ALA D 53 -1 O ILE D 51 N PHE D 43 SHEET 1 AA3 2 CYS A 51 HIS A 52 0 SHEET 2 AA3 2 THR C 10 CYS C 11 -1 O CYS C 11 N CYS A 51 SHEET 1 AA4 2 SER A 188 SER A 191 0 SHEET 2 AA4 2 LEU A 194 LEU A 197 -1 O LEU A 194 N SER A 191 SHEET 1 AA5 3 LEU C 25 ARG C 30 0 SHEET 2 AA5 3 VAL C 41 THR C 45 -1 O LYS C 44 N SER C 27 SHEET 3 AA5 3 GLU C 50 ALA C 53 -1 O ILE C 51 N PHE C 43 SSBOND 1 CYS B 51 CYS B 276 1555 1555 2.03 SSBOND 2 CYS B 129 CYS B 195 1555 1555 2.03 SSBOND 3 CYS D 11 CYS D 36 1555 1555 2.03 SSBOND 4 CYS D 12 CYS D 52 1555 1555 2.03 SSBOND 5 CYS A 51 CYS A 276 1555 1555 2.03 SSBOND 6 CYS A 129 CYS A 195 1555 1555 2.03 SSBOND 7 CYS C 11 CYS C 36 1555 1555 2.03 SSBOND 8 CYS C 12 CYS C 52 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000